Published in Drug Week, August 1st, 2003
"Allergic cutaneous reactions to heparin are a diagnostic, but mainly therapeutic challenge because an alternative anticoagulant treatment is essential. We report the case of a 24-year-old woman who, during her first pregnancy, developed a delayed type hypersensitivity reaction induced by low molecular weight heparin (LMWH) given at a prophylactic dose," researchers in France report.
"Because this patient exhibited crossreactivity with all other available LMWHs, she was given a synthetic heparinoid (danaparoid, Orgaran), and this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.